Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol-Driven Continuous Infusion Versus Intermittent Bolus Heparin During Atrial Fibrillation Ablation

NCT07361081 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07361081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07361081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol-Driven Continuous Infusion Versus Intermittent Bolus Heparin During Atrial Fibrillation Ablation
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2022
Completion date
December 31, 2028
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ablation, atrial fibrillation (af)